Log in to save to my catalogue

POS0918 TARGET-CONTROLLED INFUSION (TCI) WITH PROPOFOL AND REMIFENTANIL FOR PROCEDURAL SEDATION AND...

POS0918 TARGET-CONTROLLED INFUSION (TCI) WITH PROPOFOL AND REMIFENTANIL FOR PROCEDURAL SEDATION AND...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1136_annrheumdis_2022_eular_4569

POS0918 TARGET-CONTROLLED INFUSION (TCI) WITH PROPOFOL AND REMIFENTANIL FOR PROCEDURAL SEDATION AND ANALGESIA (PSA) IN PATIENTS WITH SYSTEMIC SCLEROSIS (SSC) UNDERGOING AUTOLOGOUS FAT GRAFTING PROCEDURES

About this item

Full title

POS0918 TARGET-CONTROLLED INFUSION (TCI) WITH PROPOFOL AND REMIFENTANIL FOR PROCEDURAL SEDATION AND ANALGESIA (PSA) IN PATIENTS WITH SYSTEMIC SCLEROSIS (SSC) UNDERGOING AUTOLOGOUS FAT GRAFTING PROCEDURES

Journal title

Annals of the rheumatic diseases, 2022-06, Vol.81, p.759

Language

English

Formats

More information

Alternative Titles

Full title

POS0918 TARGET-CONTROLLED INFUSION (TCI) WITH PROPOFOL AND REMIFENTANIL FOR PROCEDURAL SEDATION AND ANALGESIA (PSA) IN PATIENTS WITH SYSTEMIC SCLEROSIS (SSC) UNDERGOING AUTOLOGOUS FAT GRAFTING PROCEDURES

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_crossref_primary_10_1136_annrheumdis_2022_eular_4569

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1136_annrheumdis_2022_eular_4569

Other Identifiers

ISSN

0003-4967

DOI

10.1136/annrheumdis-2022-eular.4569

How to access this item